Detailed information for compound 664212

Basic information

Technical information
  • TDR Targets ID: 664212
  • Name: 5-(4-chlorophenyl)-N-[3-methoxy-4-(2-methylpr opanoylamino)phenyl]furan-2-carboxamide
  • MW: 412.866 | Formula: C22H21ClN2O4
  • H donors: 2 H acceptors: 2 LogP: 4.64 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc(ccc1NC(=O)C(C)C)NC(=O)c1ccc(o1)c1ccc(cc1)Cl
  • InChi: 1S/C22H21ClN2O4/c1-13(2)21(26)25-17-9-8-16(12-20(17)28-3)24-22(27)19-11-10-18(29-19)14-4-6-15(23)7-5-14/h4-13H,1-3H3,(H,24,27)(H,25,26)
  • InChiKey: DDRGTPJBTJRGKX-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 5-(4-chlorophenyl)-N-[3-methoxy-4-[(2-methyl-1-oxopropyl)amino]phenyl]-2-furancarboxamide
  • 5-(4-chlorophenyl)-N-[4-(isobutyrylamino)-3-methoxy-phenyl]-2-furamide
  • ZINC01101327
  • STK336824

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0029 0.0404 0.155
Brugia malayi glutathione reductase 0.0085 0.2605 1
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0193 0.6921 0.8898
Treponema pallidum NADH oxidase 0.0029 0.0404 1
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.0029 0.0404 1
Plasmodium falciparum thioredoxin reductase 0.0085 0.2605 1
Trypanosoma brucei dihydrolipoamide dehydrogenase 0.0029 0.0404 0.155
Giardia lamblia NADH oxidase lateral transfer candidate 0.0029 0.0404 1
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.0029 0.0404 1
Mycobacterium tuberculosis Probable oxidoreductase 0.0214 0.7778 1
Mycobacterium tuberculosis Probable reductase 0.0193 0.6921 0.8898
Leishmania major acetoin dehydrogenase e3 component-like protein 0.0029 0.0404 0.155
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0214 0.7778 1
Trichomonas vaginalis glutathione reductase, putative 0.0029 0.0404 1
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0193 0.6921 0.8898
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0029 0.0404 0.155
Plasmodium vivax thioredoxin reductase, putative 0.0085 0.2605 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0045 0.1027 0.3912
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0045 0.1027 0.3912
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0214 0.7778 1
Mycobacterium tuberculosis Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot 0.0029 0.0404 0.0519
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0029 0.0404 1
Trypanosoma cruzi trypanothione reductase, putative 0.0029 0.0404 0.155
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0045 0.1027 0.3943
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0085 0.2605 0.3349
Leishmania major dihydrolipoamide dehydrogenase, putative 0.0029 0.0404 0.155
Plasmodium falciparum glutathione reductase 0.0085 0.2605 1
Leishmania major 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein 0.0029 0.0404 0.155
Trypanosoma cruzi trypanothione reductase, putative 0.0085 0.2605 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0045 0.1027 0.1027
Plasmodium vivax glutathione reductase, putative 0.0085 0.2605 1
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0045 0.1027 0.3943
Loa Loa (eye worm) thioredoxin reductase 0.0085 0.2605 1
Echinococcus granulosus dihydrolipoamide dehydrogenase 0.0029 0.0404 0.1538
Plasmodium falciparum glutathione reductase 0.0029 0.0404 0.155
Toxoplasma gondii pyruvate dehydrogenase complex subunit PDH-E3II 0.0029 0.0404 0.155
Trypanosoma brucei dihydrolipoamide dehydrogenase, point mutation 0.0029 0.0404 0.155
Plasmodium vivax dihydrolipoyl dehydrogenase, apicoplast, putative 0.0029 0.0404 0.155
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0045 0.1027 0.3912
Echinococcus granulosus thioredoxin glutathione reductase 0.0085 0.2625 1
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.0029 0.0404 0.155
Echinococcus multilocularis dihydrolipoamide dehydrogenase 0.0029 0.0404 0.1538
Plasmodium falciparum dihydrolipoyl dehydrogenase, apicoplast 0.0029 0.0404 0.155
Plasmodium falciparum dihydrolipoyl dehydrogenase, mitochondrial 0.0029 0.0404 0.155
Leishmania major trypanothione reductase 0.0085 0.2605 1
Trichomonas vaginalis mercuric reductase, putative 0.0029 0.0404 1
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0193 0.6921 0.8898
Plasmodium vivax dihydrolipoyl dehydrogenase, mitochondrial, putative 0.0029 0.0404 0.155
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0193 0.6921 0.8898
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0214 0.7778 1
Echinococcus multilocularis thioredoxin glutathione reductase 0.0085 0.2625 1
Brugia malayi alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase 0.0022 0.0094 0.0361
Trypanosoma brucei dihydrolipoamide dehydrogenase 0.0029 0.0404 0.155
Brugia malayi Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein 0.0022 0.0094 0.0361
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0029 0.0404 0.155
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0045 0.1027 0.1027
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0029 0.0404 0.155
Brugia malayi Thioredoxin reductase 0.0085 0.2605 1
Mycobacterium ulcerans flavoprotein disulfide reductase 0.0029 0.0404 1
Entamoeba histolytica exodeoxyribonuclease III, putative 0.0019 0 0.5
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0029 0.0404 1
Trypanosoma brucei dihydrolipoyl dehydrogenase 0.0029 0.0404 0.155
Schistosoma mansoni dihydrolipoamide dehydrogenase 0.0029 0.0404 0.0404
Trypanosoma cruzi dihydrolipoyl dehydrogenase, putative 0.0029 0.0404 0.155
Loa Loa (eye worm) glutathione reductase 0.0085 0.2605 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0045 0.1027 0.3912
Toxoplasma gondii NADPH-glutathione reductase 0.0029 0.0404 0.155
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0045 0.1027 0.1027
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0029 0.0404 0.155
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0029 0.0404 0.5
Mycobacterium tuberculosis Probable dehydrogenase 0.0193 0.6921 0.8898
Plasmodium falciparum thioredoxin reductase 0.0029 0.0404 0.155
Leishmania major dihydrolipoamide dehydrogenase, putative 0.0029 0.0404 0.155
Trypanosoma cruzi dihydrolipoyl dehydrogenase, putative 0.0029 0.0404 0.155
Trypanosoma cruzi dihydrolipoamide dehydrogenase, putative 0.0029 0.0404 0.155
Toxoplasma gondii thioredoxin reductase 0.0085 0.2605 1
Trypanosoma brucei trypanothione reductase 0.0085 0.2605 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.